XML 35 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Assets and Liabilities
12 Months Ended
Dec. 31, 2020
Fair Value of Financial Assets and Liabilities  
Fair Value of Financial Assets and Liabilities

3.           Fair Value of Financial Assets and Liabilities

The following tables present information about the Company’s financial instruments measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value Measurements

​

​

as of December 31, 2020 Using:

​

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

 

​

  

 

​

  

 

​

  

 

​

  

Restricted cash — money market funds

​

$

210

​

$

—

​

$

—

​

$

210

Cash equivalents — money market funds

​

 

22,942

​

​

—

​

​

—

​

 

22,942

Cash equivalents — U.S. Treasury notes

​

 

—

​

​

72,695

​

​

—

​

 

72,695

Short-term investments — U.S. Treasury notes

​

​

—

​

​

209,444

​

​

—

​

​

209,444

​

​

$

23,152

​

$

282,139

​

$

—

​

$

305,291

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value Measurements

​

​

as of December 31, 2019 Using:

​

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

 

​

  

 

​

  

 

​

  

 

​

  

Restricted cash — money market funds

​

$

210

​

$

—

​

$

—

​

$

210

Cash equivalents — money market funds

​

 

25,207

​

​

—

​

​

—

​

 

25,207

Cash equivalents — U.S. Treasury notes

​

 

—

​

​

10,192

​

​

—

​

 

10,192

Short-term investments — U.S. Treasury notes

​

​

—

​

​

186,452

​

​

—

​

​

186,452

​

​

$

25,417

​

$

196,644

​

$

—

​

$

222,061

​

During the years ended December 31, 2020 and 2019 there were no transfers between Level 1, Level 2 and Level 3. The money market funds were valued using quoted prices in active markets, which represent a Level 1 measurement in the fair value hierarchy. The Company's cash equivalents and short-term investments as of December 31, 2020 and 2019 included U.S. Treasury notes, which are not traded on a daily basis and, therefore, represent a Level 2 measurement in the fair value hierarchy at each period end.

​

Cash equivalents and short-term investments as of December 31, 2020 and 2019 consisted of U.S. Treasury notes which investments were each due within six months of such date.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Gross

​

Gross

​

​

​

​

Amortized

​

Unrealized

​

Unrealized

​

Fair

​

​

Cost

​

Gains

​

Losses

​

Value

December 31, 2020

​

​

​

​

​

​

​

​

​

​

​

​

Cash equivalents — U.S. Treasury notes

​

$

72,694

​

$

1

​

$

—

​

$

72,695

Short-term investments — U.S. Treasury notes

​

​

209,459

​

​

4

​

​

(19)

​

​

209,444

​

​

$

282,153

​

$

5

​

$

(19)

​

$

282,139

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Gross

​

Gross

​

​

​

​

Amortized

​

Unrealized

​

Unrealized

​

Fair

​

​

Cost

​

Gains

​

Losses

​

Value

December 31, 2019

​

​

​

​

​

​

​

​

​

​

​

​

Cash equivalents — U.S. Treasury notes

​

$

10,191

​

$

1

​

$

—

​

$

10,192

Short-term investments — U.S. Treasury notes

​

​

186,415

​

​

44

​

​

(7)

​

​

186,452

​

​

$

196,606

​

$

45

​

$

(7)

​

$

196,644

​

As of December 31, 2020, the Company held 17 securities that were in an unrealized loss position. The aggregate fair value of securities held by the Company in an unrealized loss position was $107,753 at December 31, 2020. As of December 31, 2019, the Company held seven securities that were in an unrealized loss position. The aggregate fair value of securities held by the Company in an unrealized loss position was $43,107 at December 31, 2019. As of both December 31, 2020 and 2019, these securities were held by the Company in an unrealized loss position for

less than 12 months. The Company determined that there was no material change in the credit risk of these securities. As a result, the Company determined it did not hold any investments with an other-than-temporary impairment as of December 31, 2020 and 2019.